NCT05987644 2026-04-08
DURABLE
Hoosier Cancer Research Network
Phase 1/2 Recruiting
Clinical Trials
63 trialsNCT03508752 2026-03-27
Neurocognitive Decline in Patients With Brain Metastases
University of Texas Southwestern Medical Center
Phase 1/2 Active not recruiting
NCT05789589 2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2 Recruiting
NCT04785287 2026-03-03
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT04923542 2026-02-06
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Recruiting
NCT04711824 2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2 Recruiting
NCT04536805 2025-12-08
REPAIR
Institut Cancerologie de l'Ouest
Phase 1/2 Recruiting
NCT06238921 2025-12-05
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Recruiting
NCT03767582 2025-12-03
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT04021043 2025-12-03
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT06439888 2025-12-01
LySATRA
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
NCT02696993 2025-11-10
Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT00492817 2025-10-24
Evaluation of Single Session Stereotactic Body Radiotherapy
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT02444741 2025-10-09
Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT04977375 2025-09-03
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Cedars-Sinai Medical Center
Phase 1/2 Recruiting
NCT03383302 2025-08-01
STILE
Royal Marsden NHS Foundation Trust
Phase 1/2 Completed
NCT01891318 2025-07-02
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Case Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT04194554 2025-06-04
ASCLEPIuS
University of Michigan Rogel Cancer Center
Phase 1/2 Active not recruiting
NCT06940921 2025-04-27
SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases
First Affiliated Hospital of Chongqing Medical University
Phase 1/2 Active not recruiting
NCT06725121 2024-12-16
MacroTrans
University Health Network, Toronto
Phase 1/2 Recruiting
NCT04220775 2024-11-07
Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT04098432 2024-09-23
CA209-9KH
University Hospital Hradec Kralove
Phase 1/2 Completed
NCT03050554 2024-08-09
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
Phase 1/2 Terminated
NCT02085304 2024-04-19
Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM
St. Joseph's Hospital and Medical Center, Phoenix
Phase 1/2 Terminated
NCT02581787 2024-03-27
SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer
Stanford University
Phase 1/2 Completed
NCT02782715 2024-03-20
Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma
University of Wisconsin, Madison
Phase 1/2 Terminated
NCT06243003 2024-02-07
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Fudan University
Phase 1/2 Recruiting
NCT03749460 2023-12-29
Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers
University of Washington
Phase 1/2 Completed
NCT03618134 2023-11-18
Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner
Jonsson Comprehensive Cancer Center
Phase 1/2 Terminated
NCT02407171 2023-10-31
Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC
Yale University
Phase 1/2 Completed
NCT03399552 2023-10-23
Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT05451173 2023-10-03
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
Xuanwu Hospital, Beijing
Phase 1/2 Unknown
NCT06040177 2023-09-15
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Phase 1/2 Unknown
NCT05915481 2023-06-23
SCARCE
Peking University Third Hospital
Phase 1/2 Unknown
NCT03522584 2023-06-12
Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
University of Washington
Phase 1/2 Terminated
NCT00547339 2022-12-07
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT05641233 2022-12-07
FIBROPANC-1
Erasmus Medical Center
Phase 1/2 Unknown
NCT05265650 2022-07-19
Noelia
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2 Unknown
NCT02563691 2022-03-08
CROP
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT05131711 2021-11-23
CSREIG
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT01497808 2021-08-10
RADVAX™: A STRATIFIED PHASE I/II DOSE ESCALATION TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOLLOWED BY IPILIMUMAB IN METASTATIC MELANOMA
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT01120639 2021-08-06
Tx-Treatment
Stanford University
Phase 1/2 Completed
NCT02581384 2021-04-30
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT00152906 2020-08-14
Stereotactic Radiotherapy (SRT) Liver (COLD 1)
University Health Network, Toronto
Phase 1/2 Completed
NCT04086290 2020-02-12
Oligomet_DK
Herlev Hospital
Phase 1/2 Recruiting
NCT00591838 2019-07-30
SBRT
Washington University School of Medicine
Phase 1/2 Completed
NCT01543672 2019-06-27
VOLUMES
The Netherlands Cancer Institute
Phase 1/2 Completed
NCT00777894 2019-05-15
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Swiss Cancer Institute
Phase 1/2 Completed
NCT03446911 2018-02-27
Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery
Amsterdam UMC, location VUmc
Phase 1/2 Unknown
NCT00311597 2017-03-14
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 1/2 Completed